Indolent B-cell Lymphoma

Explore clinical trials studying Indolent B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Indolent B-cell Lymphoma trial results

Completed

NCT02836925

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: A.O. Spedali Civili Brescia, BS, Italy

Irccs Centro Di Riferimento Oncologico (Cro) Aviano, Pordenone, Italy

Ospedale San Bortolo Vicenza, VI, Italy

Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milan, Italy

View all 13 locations

Completed

NCT02846935

Conditions: Aggressive B-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Completed

NCT01805375

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations: Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

The Churchill Hospital Oxford, United Kingdom

Derriford Hospital Plymouth, United Kingdom

Completed

NCT00895661

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States